Niva Bupa Health Insurance Company PE ratio history and valuation
NSE: NIVABUPABSE: 544286InsuranceSmall Cap
Niva Bupa Health Insurance Company Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2024 · Issue price ₹74
Last close ₹72.82up ₹0.04 (0.06%)BSE ₹73.46
Share price at the NSE close on 29 Oct 2026. Previous close ₹72.78.
29 Oct: open ₹72.78, high ₹74.85, low ₹71.02
52-week range of traded prices to 29 Oct 2026
₹67.50Low, 24 Mar 2026₹91.40High, 31 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13,469 Cr441st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- SolvencySolvency ratio. The capital the insurer holds ÷ the capital the regulator requires it to hold, as the insurer states it; insurers write it in different ways, so it is read as the one multiple between 1 and 5 it can be, and not given outside that. At the end of Mar 2026. For the company alone, not its group: the regulator measures it company by company. Solvency ratio in the glossary
- 2.49times the capital required
- Gross premiumGross premium. Premium on the policies sold and renewed in the period, before the part passed on to reinsurers: a general insurer's gross premiums written, a life insurer's gross premium income. For the year to Mar 2026. For the company alone, not its group: the regulator measures it company by company. Gross premium in the glossary
- ₹8,586 Cr
- Combined ratioCombined ratio. Claims plus expenses as a percentage of premium, as the general insurer states it, in per cent on the one scale its filing writes all its ratios in; not given where that scale cannot be told. For the year to Mar 2026. For the company alone, not its group: the regulator measures it company by company. Combined ratio in the glossary
- 103.39%
- Claims ratioClaims ratio. Claims incurred as a percentage of premium earned, as the general insurer states it, in per cent on the one scale its filing writes all its ratios in; not given where that scale cannot be told, or where the filing's own amounts show it written on another scale or rounded to the whole per cent. For the year to Mar 2026. For the company alone, not its group: the regulator measures it company by company. Claims ratio in the glossary
- 68.11%
- Expense ratioExpense ratio. The costs of running the insurance business, commission included, as a percentage of premium, as the insurer states it, in per cent on the one scale its filing writes all its ratios in; not given where that scale cannot be told, or where the filing's own amounts show it written on another scale or rounded to the whole per cent. For the year to Mar 2026. For the company alone, not its group: the regulator measures it company by company. Expense ratio in the glossary
- 33.70%
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 14,47,24178.8% delivered
Niva Bupa Health Insurance Company's dividend yield on 29 Oct 2026, each against its own history of up to a year. It has no P/E yet: twelve months of its results are not on record.
Niva Bupa Health Insurance Company PE ratio and valuation against its own history
- Price to earningsNo results for a period ending in the last six months, or nine for a company filing half-yearly
- Price to bookNo results for a period ending in the last six months, or nine for a company filing half-yearly
- Price to salesPrice to sales, trailing. Market cap divided by the revenue of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what investors pay for each rupee of a year's sales.Not used for a lender or an insurer
- EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.Not used for a lender or an insurer
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.0.00%today
1 year
Median 0.00%Today is at or above 100% of the 247 days
- Earnings yieldEarnings yield. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) as a percentage of market cap, the P/E turned upside down.No results for a period ending in the last six months, or nine for a company filing half-yearly
Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
How each ratio is worked out, with today's figures
- Market cap =Close×Shares in issueShares in issue. The shares in issue in the latest shareholding filing.1,84,96,44,703at 30 Sep 2026
Niva Bupa Health Insurance Company valuation at each year end
On the last trading day of each March, the month the company's year ends.
| Ratio | Mar 2025 | Mar 2026 |
|---|---|---|
| Market cap (₹ crore)Market capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. | 14,265 | 12,969 |
| Price to earnings | No results | Loss |
| Price to book | No results | 4.5 |
| Price to sales | Lender or insurer | Lender or insurer |
| EV to EBITDA | Lender or insurer | Lender or insurer |
| Dividend yield | 0.00% | 0.00% |
| Earnings yield | No results | −0.1% |
A ratio that does not exist on the day says why in its cell.
Niva Bupa Health Insurance Company market cap, since Nov 2024
The last trading day of each month.
Market cap, ₹ crore
- Market cap
Dividends and the public's market cap
From the close on 29 Oct 2026.
- Dividends, last 12 monthsDividends per share, last 12 months. Dividends per share with an ex-date in the last twelve months, restated for any split or bonus since.
- None
- Public's market capPublic's market cap. The market value of the shares held by everyone other than the promoters, the group that set up or controls the company.
- ₹6,022 Cr
Against Insurance
13 listed companies in Insurance, each priced on its last trading day; Niva Bupa Health Insurance Company is 11th among them by market cap. Each median leaves out Niva Bupa Health Insurance Company itself and takes the other companies that have the figure.
- Industry median P/EIndustry median trailing P/E. The middle trailing P/E of the listed companies in the same industry that have one, leaving out the company itself and any P/E above 200.
- 34.0Across 11 other companies
- Industry median P/BIndustry median P/B. The middle P/B of the listed companies in the same industry that have one, leaving out the company itself.
- 4.3Across 12 other companies
- Industry median dividend yieldIndustry median dividend yield. The middle dividend yield of the listed companies in the same industry that paid a dividend in the last twelve months, leaving out the company itself.
- 0.67%Across 9 other companies
| Company | |||||
|---|---|---|---|---|---|
 ICICI Life InsuranceICICILIFE | 59,783 | 33.98 | 4.09 | – | 0.40% |
 General Insurance Corporation of IndiaGICRE | 56,544 | 6.35 | 0.93 | – | 4.11% |
 Max Financial ServicesMFSL | 41,828 | – | 7.31 | 115.7 | 0.00% |
 Star Health and Allied Insurance CompanySTARHEALTH | 31,338 | 29.73 | 4.13 | – | 0.00% |
 The New India Assurance CompanyNIACL | 27,462 | 38.29 | 1.12 | – | 0.90% |
 Go Digit General InsuranceGODIGIT | 24,461 | 49.68 | 5.17 | – | 0.00% |
| Niva Bupa Health Insurance CompanyNIVABUPA | 13,469 | – | – | – | 0.00% |
 Canara HSBC Life Insurance CompanyCANHLIFE | 11,831 | 88.58 | 7.22 | – | 0.32% |
 Medi Assist Healthcare ServicesMEDIASSIST | 2,225 | 23.87 | 2.65 | 11.8 | 0.67% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record; for ROCE and EV/EBITDA, where the company is a lender or an insurer. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page. Income growth is the growth of everything the company earns: interest, fees, premiums and the rest.